Trials / Unknown
UnknownNCT04670445
Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 210 (estimated)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to refine and pilot test educational material developed to educate and support patients receiving immunotherapy for advanced cancer. The intervention is an educational video and question prompt list (QPL) to promote communication between patients, caregivers, and the oncology team about the risks and benefits of immunotherapy.
Detailed description
This two-part study will 1) refine and 2) pilot test an intervention to improve participant's and caregiver knowledge and increase communication with the oncology team about immunotherapy. * The intervention involves watching a video developed to educate patients regarding the risks, benefits, and potential outcomes of immunotherapy treatment and reviewing an immunotherapy-focused QPL prior to ICI initiation. * In Part 1 of this study, investigators will conduct a small open pilot to refine the intervention and study procedures. * In Part 2, investigators will conduct a single-site pilot randomized controlled trial including 130 patients and their caregivers, to evaluate the feasibility of intervention delivery, and the preliminary efficacy of the intervention in improving patient and caregiver knowledge.
Conditions
- Stage IV Melanoma
- Advanced Lung Cancer
- Stage IV Non-Small Cell Lung Cancer
- Unresectable Non-Small Cell Lung Carcinoma
- Unresectable Stage III Non-Small Cell Lung Cancer
- Small Cell Lung Cancer Extensive Stage
- Stage IV Merkel Cell Carcinoma
- Stage IV Cutaneous Squamous Cell Carcinoma
- Stage IV Basal Cell Carcinoma
- Stage IV Breast Cancer
- Stage IV Colorectal Cancer
- Stage IV Gastric Cancer
- Stage IV Esophageal Cancer
- Stage IV Hepatocellular Cancer
- Stage IV Renal Cell Carcinoma
- Stage IV Bladder Cancer
- Stage IV Head and Neck Squamous Cell Carcinoma
- Stage IV Cervical Cancer
- Stage IV Endometrial Cancer
- Stage IV Mesothelioma
- Immunotherapy
- Immune Checkpoint Inhibitors
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Educational Video and QPL List | The intervention includes a 15-minute educational video and a 2- page list of suggested questions to review with oncology team about immunotherapy. |
| OTHER | Usual Care | Surveys |
Timeline
- Start date
- 2021-01-23
- Primary completion
- 2023-03-23
- Completion
- 2024-04-01
- First posted
- 2020-12-17
- Last updated
- 2023-10-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04670445. Inclusion in this directory is not an endorsement.